RTW INVESTMENTS, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$52,433,000
+1.3%
582,265
+10.0%
0.77%
-65.6%
Q1 2020$51,772,000
-33.8%
529,261
-12.6%
2.23%
-24.4%
Q4 2019$78,168,000
+43.3%
605,762
-16.4%
2.95%
-9.1%
Q3 2019$54,555,000
-40.6%
724,311
+19.9%
3.24%
-33.8%
Q2 2019$91,814,000
+127.8%
604,236
+78.7%
4.90%
+78.2%
Q1 2019$40,310,000
+0.9%
338,199
-7.6%
2.75%
-26.0%
Q4 2018$39,932,000
-21.3%
365,911
+16.5%
3.72%
+22.4%
Q3 2018$50,725,000
-60.8%
314,070
-67.9%
3.04%
-67.4%
Q2 2018$129,345,000
+153.6%
978,551
+42.2%
9.33%
+92.2%
Q1 2018$50,994,000688,2714.85%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders